Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Nuclear Medicine

  Free Subscription


Articles published in Nucl Med Commun

Retrieve available abstracts of 202 articles:
HTML format
Text format



Single Articles


    November 2018
  1. DEMIRCI E, Kabasakal L, Sahin OE, Akgun E, et al
    Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
    Nucl Med Commun. 2018 Nov 2. doi: 10.1097/MNM.0000000000000942.
    PubMed     Text format     Abstract available


  2. ABUQBEITAH M, Demir M, Kabasakal L, Cavdar I, et al
    Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer.
    Nucl Med Commun. 2018;39:969-975.
    PubMed     Text format     Abstract available


  3. OKADA Y, Shiraishi M, Nakamura H, Maki F, et al
    Usefulness of the combination of iodine-123-metaiodobenzylguanidine scintigraphy and iodine-123-ioflupane scintigraphy in new-onset Parkinson's disease.
    Nucl Med Commun. 2018;39:983-988.
    PubMed     Text format     Abstract available


    October 2018
  4. PRABHU M, Kumari G, Damle NA, Arora G, et al
    Assessment of the role of early dynamic PET/CT with 18F-fluorocholine in detection of parathyroid lesions in patients with primary hyperparathyroidism.
    Nucl Med Commun. 2018 Oct 30. doi: 10.1097/MNM.0000000000000924.
    PubMed     Text format     Abstract available


  5. BASHIR U, Foot O, Wise O, Siddique MM, et al
    Investigating the histopathologic correlates of 18F-FDG PET heterogeneity in non-small-cell lung cancer.
    Nucl Med Commun. 2018 Oct 30. doi: 10.1097/MNM.0000000000000925.
    PubMed     Text format     Abstract available


  6. BETTS HM, O'Connor RA, Christian JA, Vinayakamoorthy V, et al
    Hypoxia imaging with [18F]HX4 PET in squamous cell head and neck cancers: a pilot study for integration into treatment planning.
    Nucl Med Commun. 2018 Oct 26. doi: 10.1097/MNM.0000000000000933.
    PubMed     Text format     Abstract available


  7. SHARMA A, Pandey AK, Mohan A, Bhalla AS, et al
    Standardization of image reconstruction parameters for dynamic fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
    Nucl Med Commun. 2018 Oct 26. doi: 10.1097/MNM.0000000000000923.
    PubMed     Text format     Abstract available


  8. HALL M
    Artificial intelligence and nuclear medicine.
    Nucl Med Commun. 2018 Oct 22. doi: 10.1097/MNM.0000000000000937.
    PubMed     Text format    


  9. KLEIN R, Razavi S, Memon R, Zuckier LS, et al
    An electronic technetium-99m-diethylenetriaminepentaacetic acid glomerular filtration rate spreadsheet with novel embedded quality assurance features.
    Nucl Med Commun. 2018 Oct 22. doi: 10.1097/MNM.0000000000000929.
    PubMed     Text format     Abstract available


  10. EVBUOMWAN O, Momodu J, Purbhoo K, Vangu MDT, et al
    Evaluation of technetium-99m metastable nanocolloid as an imaging agent for performing milk scans.
    Nucl Med Commun. 2018 Oct 17. doi: 10.1097/MNM.0000000000000934.
    PubMed     Text format     Abstract available


  11. VUKOMANOVIC VR, Matovic M, Doknic M, Ignjatovic V, et al
    Clinical usefulness of 99mTc-HYNIC-TOC, 99mTc(V)-DMSA, and 99mTc-MIBI SPECT in the evaluation of pituitary adenomas.
    Nucl Med Commun. 2018 Oct 16. doi: 10.1097/MNM.0000000000000931.
    PubMed     Text format     Abstract available


  12. VADI SK, Mittal BR, Sood A, Singh G, et al
    Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer.
    Nucl Med Commun. 2018 Oct 11. doi: 10.1097/MNM.0000000000000928.
    PubMed     Text format     Abstract available


  13. MANSOOR NM, Thust S, Militano V, Fraioli F, et al
    PET imaging in glioma: techniques and current evidence.
    Nucl Med Commun. 2018 Oct 9. doi: 10.1097/MNM.0000000000000914.
    PubMed     Text format     Abstract available



  14. The prognostic and diagnostic value of 18F-FDG PET/CT for assessment of symptomatic osteoarthritis: Erratum.
    Nucl Med Commun. 2018;39:960.
    PubMed     Text format    


  15. SERRELI G, Ruffini L, Ortenzia O, Cidda C, et al
    Radiation dose reduction in myocardial perfusion imaging single-photon emission computed tomography/computed tomography using a dose-tracking software.
    Nucl Med Commun. 2018;39:894-900.
    PubMed     Text format     Abstract available


  16. YAZICI B, Bulut IK, Oral A, Sezer TO, et al
    Early predictive value of baseline renal transplant scintigraphy in pediatric patients.
    Nucl Med Commun. 2018;39:901-907.
    PubMed     Text format     Abstract available


  17. KIM DH, Wit H, Thurston M
    Artificial intelligence in the diagnosis of Parkinson's disease from ioflupane-123 single-photon emission computed tomography dopamine transporter scans using transfer learning.
    Nucl Med Commun. 2018;39:887-893.
    PubMed     Text format     Abstract available


  18. LEE SF, Lichtenstein M, Hughes P, Sivaratnam D, et al
    Utility of MAG3 scintigraphy with the use of a 2 min uptake parameter in the assessment of postsurgical renal transplant complications.
    Nucl Med Commun. 2018;39:921-927.
    PubMed     Text format     Abstract available


  19. NOTGHI A, Hansrod S
    National survey of gastric emptying studies in the UK.
    Nucl Med Commun. 2018;39:881-886.
    PubMed     Text format     Abstract available


  20. LIU S, Feng Z, Jiang Z, Wen H, et al
    Prognostic predictive value of preoperative intratumoral 2-deoxy-2-(18F)fluoro-D-glucose uptake heterogeneity in patients with high-grade serous ovarian cancer.
    Nucl Med Commun. 2018;39:928-935.
    PubMed     Text format     Abstract available


    September 2018
  21. NAKAJIMA R, Nagao M, Ohashi R, Muragaki Y, et al
    Modified fractal analysis of methionine positron emission tomography images for predicting prognosis in newly diagnosed patients with glioma.
    Nucl Med Commun. 2018 Sep 21. doi: 10.1097/MNM.0000000000000917.
    PubMed     Text format     Abstract available


  22. XUE J, Liu Y, Ji T, Zhao A, et al
    Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia.
    Nucl Med Commun. 2018 Sep 19. doi: 10.1097/MNM.0000000000000921.
    PubMed     Text format     Abstract available


  23. FUJIOKA T, Kubota K, Kikuchi Y, Tsuchiya J, et al
    The feasibility of using 18F-FDG-PET/CT in patients with mucinous breast carcinoma.
    Nucl Med Commun. 2018 Sep 18. doi: 10.1097/MNM.0000000000000910.
    PubMed     Text format     Abstract available


  24. GUNDOGAN C, Cermik TF, Erkan E, Yardimci AH, et al
    Role of contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of renal tumors.
    Nucl Med Commun. 2018 Sep 18. doi: 10.1097/MNM.0000000000000915.
    PubMed     Text format     Abstract available


  25. KANGASMAA TS, Constable C, Sohlberg AO
    Evaluation of quantitative 123I and 131I SPECT with Monte Carlo-based down-scatter compensation.
    Nucl Med Commun. 2018 Sep 14. doi: 10.1097/MNM.0000000000000920.
    PubMed     Text format     Abstract available


  26. ANNOVAZZI A, Rea S, Vici P, Fabi A, et al
    Dual-time 18F-FDG PET/CT for the detection of liver metastases in breast cancer.
    Nucl Med Commun. 2018 Sep 13. doi: 10.1097/MNM.0000000000000918.
    PubMed     Text format     Abstract available


  27. SASIKUMAR A, Joy A, Pillai AMR, Oommen KE, et al
    Gallium 68-PSMA PET/CT for lesion characterization in suspected cases of prostate carcinoma.
    Nucl Med Commun. 2018 Sep 13. doi: 10.1097/MNM.0000000000000906.
    PubMed     Text format     Abstract available


  28. MOSAYEBNIA M, Hajiramezanali M, Shahhosseini S, Hajiagha Bozorgi A, et al
    Docking, synthesis, in-vitro evaluation, and optimization of reaction conditions for direct radiolabeling of CGPRPPC with technetium-99m through the GAGG sequence.
    Nucl Med Commun. 2018 Sep 12. doi: 10.1097/MNM.0000000000000901.
    PubMed     Text format     Abstract available


  29. PAK K, Shin S, Kim SJ, Kim K, et al
    Meta-analysis of meta-analyses in oncologic positron emission tomography.
    Nucl Med Commun. 2018 Sep 12. doi: 10.1097/MNM.0000000000000908.
    PubMed     Text format     Abstract available


  30. ZHANG L, Sun H, Du S, Xu W, et al
    Evaluation of 18F-FDG PET/CT parameters for reflection of aggressiveness and prediction of prognosis in early-stage cervical cancer.
    Nucl Med Commun. 2018 Sep 10. doi: 10.1097/MNM.0000000000000909.
    PubMed     Text format     Abstract available


  31. WIERTS R, Conti M, Claessen AGG, Herrmann K, et al
    Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124I PET/CT imaging.
    Nucl Med Commun. 2018 Sep 7. doi: 10.1097/MNM.0000000000000911.
    PubMed     Text format     Abstract available


  32. HAIDAR M, Baassiri A, Maroun G, Barakat A, et al
    New era of PET/CT in breast cancer: high-resolution PET/dfCT.
    Nucl Med Commun. 2018 Sep 6. doi: 10.1097/MNM.0000000000000907.
    PubMed     Text format     Abstract available


  33. BARBER TW, Veysey D, Billah B, Francis P, et al
    Normal brain metabolism on FDG PET/MRI during childhood and adolescence.
    Nucl Med Commun. 2018 Sep 6. doi: 10.1097/MNM.0000000000000912.
    PubMed     Text format     Abstract available


  34. LAWAL IO, Ankrah AO, Popoola GO, Nyakale NE, et al
    18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma.
    Nucl Med Commun. 2018 Sep 5. doi: 10.1097/MNM.0000000000000905.
    PubMed     Text format     Abstract available


  35. AKTAS GE, Karamustafaoglu YA, Balta C, Sut N, et al
    Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
    Nucl Med Commun. 2018 Sep 4. doi: 10.1097/MNM.0000000000000903.
    PubMed     Text format     Abstract available


  36. FILIPPI L, Di Costanzo GG, D'Agostini A, Tortora R, et al
    Decrease in total lesion glycolysis and survival after yttrium-90-radioembolization in poorly differentiated hepatocellular carcinoma with portal vein tumour thrombosis.
    Nucl Med Commun. 2018;39:845-852.
    PubMed     Text format     Abstract available


  37. DICKINSON NJ, Kalirai C, O'Connor RA, Mullin K, et al
    Hepatic selective internal radiation therapy: how well does pretreatment 99mTc-macroaggregated albumin activity distribution and quantification agree with post-therapy bremsstrahlung imaging?
    Nucl Med Commun. 2018;39:809-817.
    PubMed     Text format     Abstract available


  38. LIU NH, Dong MJ, Liu H, Lu XL, et al
    99mTc-Phy portal perfusion index imaging helps predict the severity of hepatitis B virus cirrhosis: a preliminary study.
    Nucl Med Commun. 2018;39:818-824.
    PubMed     Text format     Abstract available


    August 2018
  39. ARAZ M, Soydal C, Ozkan E, Kir MK, et al
    The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism.
    Nucl Med Commun. 2018 Aug 22. doi: 10.1097/MNM.0000000000000899.
    PubMed     Text format     Abstract available


  40. SANLI Y, Sanli O, Has Simsek D, Subramaniam RM, et al
    68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patients.
    Nucl Med Commun. 2018 Aug 17. doi: 10.1097/MNM.0000000000000888.
    PubMed     Text format     Abstract available


  41. D'AGOSTINO GR, Lopci E, Di Brina L, Franzese C, et al
    Role of 11C-choline PET/CT in radiation therapy planning of patients with prostate cancer.
    Nucl Med Commun. 2018 Aug 17. doi: 10.1097/MNM.0000000000000894.
    PubMed     Text format     Abstract available


  42. BRINKMAN M, Jentjens S, Boone K, Anten M, et al
    Evaluation of the most commonly used (semi-)quantitative parameters of 18F-FDG PET/CT to detect malignant transformation of neurofibromas in neurofibromatosis type 1.
    Nucl Med Commun. 2018 Aug 13. doi: 10.1097/MNM.0000000000000889.
    PubMed     Text format     Abstract available


  43. AYUBCHA C, Zirakchian Zadeh M, Stochkendahl MJ, Al-Zaghal A, et al
    Quantitative evaluation of normal spinal osseous metabolism with 18F-NaF PET/CT.
    Nucl Med Commun. 2018 Aug 9. doi: 10.1097/MNM.0000000000000891.
    PubMed     Text format     Abstract available


  44. CHHABRA A, Rathore Y, Bhusari P, Vatsa R, et al
    Concentration protocol of rhenium-188 perrhenate eluted from tungsten-188/rhenium-188 generator for the preparation of high-yield rhenium-188-labelled radiopharmaceuticals.
    Nucl Med Commun. 2018 Aug 6. doi: 10.1097/MNM.0000000000000893.
    PubMed     Text format     Abstract available


  45. LIU W, Sun X, Qi Y, Jia X, et al
    Integrated texture parameter of 18F-FDG PET may be a stratification factor for the survival of nonoperative patients with locally advanced non-small-cell lung cancer.
    Nucl Med Commun. 2018;39:732-740.
    PubMed     Text format     Abstract available


  46. SUN Y, Liu S, Feng Z, Cheng J, et al
    Preoperative omental metastasis-related maximum standardized fluorine-18-fluorodeoxyglucose uptake value can predict chemosensitivity and recurrence in advanced high-grade serous ovarian cancer patients.
    Nucl Med Commun. 2018;39:761-767.
    PubMed     Text format     Abstract available


  47. DEMIRCI E, Kabasakal L, Toklu T, Ocak M, et al
    177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update.
    Nucl Med Commun. 2018;39:789-796.
    PubMed     Text format     Abstract available


  48. JIANG Z, Tang H, Shi J, Zhou Y, et al
    Myocardial stunning-induced left ventricular dyssynchrony on gated single-photon emission computed tomography myocardial perfusion imaging.
    Nucl Med Commun. 2018;39:725-731.
    PubMed     Text format     Abstract available


  49. TORIIHARA A, Daisaki H, Yamaguchi A, Yoshida K, et al
    Applying standardized uptake values in gallium-67-citrate single-photon emission computed tomography/computed tomography studies and their correlation with blood test results in representative organs.
    Nucl Med Commun. 2018;39:720-724.
    PubMed     Text format     Abstract available


    July 2018
  50. ABUBAKAR S, Jacobs D, Kotze T
    The conclusions drawn from ventilation/perfusion single-photon emission computed tomography compared with lung perfusion single-photon emission computed tomography and chest radiography in patients with suspected pulmonary thromboembolism.
    Nucl Med Commun. 2018 Jul 25. doi: 10.1097/MNM.0000000000000886.
    PubMed     Text format     Abstract available


  51. CORNELI M, Masoli O, Perea G, Meretta A, et al
    Actual impact of screening for myocardial ischemia with single-photon emission tomography among patients undergoing peripheral vascular interventions.
    Nucl Med Commun. 2018 Jul 23. doi: 10.1097/MNM.0000000000000883.
    PubMed     Text format     Abstract available


  52. WAGATSUMA K, Oda K, Sakata M, Inaji M, et al
    Validation of scatter limitation correction to eliminate scatter correction error in oxygen-15 gas-inhalation positron emission tomography images.
    Nucl Med Commun. 2018 Jul 6. doi: 10.1097/MNM.0000000000000882.
    PubMed     Text format     Abstract available


  53. NGUYEN BJ, Burt A, Baldassare RL, Smitaman E, et al
    The prognostic and diagnostic value of 18F-FDG PET/CT for assessment of symptomatic osteoarthritis.
    Nucl Med Commun. 2018;39:699-706.
    PubMed     Text format     Abstract available


  54. KIM HR, Seo M, Nah YW, Park HW, et al
    Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival.
    Nucl Med Commun. 2018;39:691-698.
    PubMed     Text format     Abstract available


  55. ARSLAN E, Cermik TF, Trabulus FDC, Talu ECK, et al
    Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer.
    Nucl Med Commun. 2018;39:680-690.
    PubMed     Text format     Abstract available


  56. LI YB, Zheng X, Wang R, Wu H, et al
    SPECT-CT versus MRI in localizing active lesions in patients with osteoporotic vertebral compression fractures.
    Nucl Med Commun. 2018;39:610-617.
    PubMed     Text format     Abstract available


  57. TSUJIMOTO M, Shirakawa S, Teramoto A, Ishiguro M, et al
    Fluctuation of quantitative values on acquisition time and the reconstruction conditions in 99mTc-SPECT.
    Nucl Med Commun. 2018;39:601-609.
    PubMed     Text format     Abstract available


  58. KURISU S, Nitta K, Sumimoto Y, Ikenaga H, et al
    Effects of atrial fibrillation on myocardial washout rate of thallium-201 on myocardial perfusion single-photon emission computed tomography.
    Nucl Med Commun. 2018;39:597-600.
    PubMed     Text format     Abstract available


    June 2018
  59. MOHAMMADINIA S, Abedi SM, Noaparast Z
    St. John's Wort accelerates the liver clearance of technetium-99-sestamibi in rats.
    Nucl Med Commun. 2018 Jun 26. doi: 10.1097/MNM.0000000000000880.
    PubMed     Text format     Abstract available


  60. CHATTERJEE A, Gupta T, Rangarajan V, Purandare N, et al
    Optimal timing of fluorine-18-fluoromisonidazole positron emission tomography/computed tomography for assessment of tumor hypoxia in patients with head and neck squamous cell carcinoma.
    Nucl Med Commun. 2018 Jun 22. doi: 10.1097/MNM.0000000000000878.
    PubMed     Text format     Abstract available


  61. EMSEN B, Benali K, Mahida B, Lariviere D, et al
    Comparison between visual and numerical metrics for the evaluation of patients with Takayasu arteritis with 18F-FDG-PET.
    Nucl Med Commun. 2018 Jun 8. doi: 10.1097/MNM.0000000000000867.
    PubMed     Text format     Abstract available


  62. MACAULEY M, Shawgi M, Ali T, Curry A, et al
    Assessment of normal reference values for thyroid uptake of technetium-99m pertechnetate in a single centre UK population.
    Nucl Med Commun. 2018 Jun 6. doi: 10.1097/MNM.0000000000000876.
    PubMed     Text format     Abstract available


  63. DEVRIESE J, Beels L, Maes A, van de Wiele C, et al
    Patient-specific lean body mass can be estimated from limited-coverage computed tomography images.
    Nucl Med Commun. 2018;39:521-526.
    PubMed     Text format     Abstract available


  64. YILDIRIM BA, Torun N, Guler OC, Onal C, et al
    Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy.
    Nucl Med Commun. 2018;39:553-563.
    PubMed     Text format     Abstract available


  65. YILMAZ R, Yumusak N, Sadic M, Atilgan HI, et al
    The scintigraphic, biodistribution and histopathological evaluation of the effect of experimental 131I administration on the gastrointestinal system and the demonstration of the Na+/I- symporter by immunohistochemistry in rats.
    Nucl Med Commun. 2018;39:511-520.
    PubMed     Text format     Abstract available


  66. CHIARAVALLOTI A, Barbagallo G, Ricci M, Sannino P, et al
    Ageing effect on 18F-DOPA and 123I-MIBG uptake: a cross-sectional study.
    Nucl Med Commun. 2018;39:539-544.
    PubMed     Text format     Abstract available


    May 2018
  67. SHARMA S, Singh AD, Sharma SK, Tripathi M, et al
    Gallium-68 DOTA-NOC PET/CT as an alternate predictor of disease activity in sarcoidosis.
    Nucl Med Commun. 2018 May 30. doi: 10.1097/MNM.0000000000000869.
    PubMed     Text format     Abstract available


  68. MALLORIE A, Chan K, Ioannidis S, Stubbs M, et al
    A case series of outcomes in isolated subsegmental pulmonary embolism on ventilation-perfusion imaging.
    Nucl Med Commun. 2018 May 25. doi: 10.1097/MNM.0000000000000866.
    PubMed     Text format     Abstract available


  69. VIJA RACARU L, Sinigaglia M, Kanoun S, Ben Bouallegue F, et al
    Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.
    Nucl Med Commun. 2018 May 21. doi: 10.1097/MNM.0000000000000850.
    PubMed     Text format     Abstract available


  70. ALBANO D, Familiari D, Gentile R, Scalisi S, et al
    Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer.
    Nucl Med Commun. 2018 May 18. doi: 10.1097/MNM.0000000000000862.
    PubMed     Text format     Abstract available


  71. SUGITA T, Kondo Y, Ishino S, Mori I, et al
    Evaluation of drug effects on cerebral blood flow and glucose uptake in un-anesthetized and un-stimulated rats: application of free-moving apparatus enabling to keep rats free during PET/SPECT tracer injection and uptake.
    Nucl Med Commun. 2018 May 15. doi: 10.1097/MNM.0000000000000863.
    PubMed     Text format     Abstract available


  72. KOUIJZER IJE, Berrevoets MAH, Aarntzen EHJG, de Vries J, et al
    18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis.
    Nucl Med Commun. 2018 May 14. doi: 10.1097/MNM.0000000000000864.
    PubMed     Text format     Abstract available


  73. LU Z, Xie J, Yan R, Yu Z, et al
    A pilot study of pancreatic islet amyloid PET imaging with [18F]FDDNP.
    Nucl Med Commun. 2018 May 5. doi: 10.1097/MNM.0000000000000849.
    PubMed     Text format     Abstract available


  74. CAOBELLI F, Popescu CE, Laudicella R, Comis A, et al
    Predictive and prognostic value of left ventricular mechanical dyssynchrony assessed by myocardial perfusion single photon emission computed tomography in asymptomatic patients under hemodialysis.
    Nucl Med Commun. 2018;39:423-429.
    PubMed     Text format     Abstract available


  75. ROSICA D, Cheng SC, Hudson M, Sakellis C, et al
    Effects of hyperglycemia on fluorine-18-fluorodeoxyglucose biodistribution in a large oncology clinical practice.
    Nucl Med Commun. 2018;39:417-422.
    PubMed     Text format     Abstract available


    April 2018
  76. BELISSANT O, Champion L, Thevenet H, Weinmann P, et al
    Value of 18F-FDG PET/CT imaging in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas.
    Nucl Med Commun. 2018 Apr 20. doi: 10.1097/MNM.0000000000000848.
    PubMed     Text format     Abstract available


  77. GRUT H, Revheim ME, Line PD, Dueland S, et al
    Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation.
    Nucl Med Commun. 2018 Apr 20. doi: 10.1097/MNM.0000000000000843.
    PubMed     Text format     Abstract available


  78. PALANISWAMY SS, Borde CR, Subramanyam P
    18F-FDG PET/CT in the evaluation of cancer cervix: Where do we stand today?
    Nucl Med Commun. 2018 Apr 20. doi: 10.1097/MNM.0000000000000851.
    PubMed     Text format     Abstract available


  79. BORAKATI A, Razack A, Cawthorne C, Roy R, et al
    A comparative study of quantitative assessment with fluorine-18-fluorodeoxyglucose positron-emission tomography and endoscopic ultrasound in oesophageal cancer.
    Nucl Med Commun. 2018 Apr 18. doi: 10.1097/MNM.0000000000000844.
    PubMed     Text format     Abstract available


  80. ALKHAWTANI RHM, Noordzij W, Glaudemans AWJM, van Rijn RS, et al
    Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma.
    Nucl Med Commun. 2018 Apr 18. doi: 10.1097/MNM.0000000000000840.
    PubMed     Text format     Abstract available


  81. OWAKI Y, Nakahara T, Shimizu T, Smith AM, et al
    Effects of breathing motion on PET acquisitions: step and shoot versus continuous bed motion.
    Nucl Med Commun. 2018 Apr 18. doi: 10.1097/MNM.0000000000000852.
    PubMed     Text format     Abstract available


  82. GOENSE L, Meziani J, van Rossum PSN, Wessels FJ, et al
    Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis.
    Nucl Med Commun. 2018 Apr 18. doi: 10.1097/MNM.0000000000000847.
    PubMed     Text format     Abstract available


  83. QIU L, Tan H, Cheng D, Shi H, et al
    The incremental clinical value of cardiac hybrid SPECT/CTA imaging in coronary artery disease.
    Nucl Med Commun. 2018 Apr 12. doi: 10.1097/MNM.0000000000000838.
    PubMed     Text format     Abstract available


  84. SCHIRMER MR, Carneiro MP, Machado LS, Chaves ALDS, et al
    Fluorine-18-fluorodeoxyglucose PET/CT in hematopoietic stem cell transplant patients with fusariosis: initial findings of a case series review.
    Nucl Med Commun. 2018 Apr 12. doi: 10.1097/MNM.0000000000000834.
    PubMed     Text format     Abstract available


  85. ZHENG M, Xie D, Pan C, Xu Y, et al
    Diagnostic value of 18F-FDG PET/MRI in recurrent pelvis malignancies of female patients: a systematic review and meta-analysis.
    Nucl Med Commun. 2018 Apr 9. doi: 10.1097/MNM.0000000000000839.
    PubMed     Text format     Abstract available


  86. SUN M, Zhang G, Guo J, Hao S, et al
    Prognostic value of pretreatment PET/CT lean body mass-corrected parameters in patients with hepatocellular carcinoma.
    Nucl Med Commun. 2018 Apr 9. doi: 10.1097/MNM.0000000000000842.
    PubMed     Text format     Abstract available


  87. LAPA P, Pedroso de Lima J
    Superiority of 18F-NaF PET/CT for the detection of bone metastases.
    Nucl Med Commun. 2018;39:344-345.
    PubMed     Text format    


  88. TATAR G, Cermik TF, Karagoz Y, Gundogan C, et al
    The value of whole-body contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of patients with laryngeal carcinoma.
    Nucl Med Commun. 2018;39:334-342.
    PubMed     Text format     Abstract available


  89. LIU S, Ju X, Feng Z, Wen H, et al
    Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patients.
    Nucl Med Commun. 2018;39:319-324.
    PubMed     Text format     Abstract available


  90. MORELAND J, Urhemaa T, van Gils M, Lotjonen J, et al
    Validation of prognostic biomarker scores for predicting progression of dementia in patients with amnestic mild cognitive impairment.
    Nucl Med Commun. 2018;39:297-303.
    PubMed     Text format     Abstract available


  91. PELI A, Camoni L, Zilioli V, Durmo R, et al
    Attenuation correction in myocardial perfusion imaging affects the assessment of infarct size in women with previous inferior infarct.
    Nucl Med Commun. 2018;39:290-296.
    PubMed     Text format     Abstract available


    March 2018
  92. DENNIS JL, Gemmell AJ, Nicol AJ
    Optimization of the CT component of SPECT-CT and establishment of local CT diagnostic reference levels for clinical practice.
    Nucl Med Commun. 2018 Mar 31. doi: 10.1097/MNM.0000000000000831.
    PubMed     Text format     Abstract available


  93. BERGERON DE, Cessna JT
    An update on 'dose calibrator' settings for nuclides used in nuclear medicine.
    Nucl Med Commun. 2018 Mar 28. doi: 10.1097/MNM.0000000000000833.
    PubMed     Text format     Abstract available


  94. VAN DIJK JD, Huizing ED, van Dalen JA, Timmer JR, et al
    Minimal starting time of data reconstruction for qualitative myocardial perfusion rubidium-82 positron emission tomography imaging.
    Nucl Med Commun. 2018 Mar 23. doi: 10.1097/MNM.0000000000000830.
    PubMed     Text format     Abstract available


  95. MANDEGARAN R, Agrawal K, Vijayanathan S, Gnanasegaran G, et al
    The value of 99mTc-MDP bone SPECT/CT in evaluation of patients with painful knee prosthesis.
    Nucl Med Commun. 2018 Mar 16. doi: 10.1097/MNM.0000000000000825.
    PubMed     Text format     Abstract available


  96. ALMEIDA LS, Araujo MC, Zantut-Wittmann DE, Assumpcao LV, et al
    Effect of thyroid-stimulating hormone in 68Ga-DOTATATE PET/CT of radioiodine-refractory thyroid carcinoma: a pilot study.
    Nucl Med Commun. 2018 Mar 14. doi: 10.1097/MNM.0000000000000823.
    PubMed     Text format     Abstract available


  97. LEE JW, Lee SW, Chang SH, Lee SM, et al
    Clinical role of bone scintigraphy in low-to-intermediate Framingham risk patients with atypical chest pain.
    Nucl Med Commun. 2018 Mar 13. doi: 10.1097/MNM.0000000000000822.
    PubMed     Text format     Abstract available


  98. ANDERSEN TB, Aleksyniene R, Boldsen SK, Gade M, et al
    Contrast-enhanced computed tomography does not improve the diagnostic value of parathyroid dual-phase MIBI SPECT/CT.
    Nucl Med Commun. 2018 Mar 6. doi: 10.1097/MNM.0000000000000818.
    PubMed     Text format     Abstract available


  99. JONNAKUTI VS, Raynor WY, Taratuta E, Werner TJ, et al
    A novel method to assess subchondral bone formation using [18F]NaF-PET in the evaluation of knee degeneration.
    Nucl Med Commun. 2018 Mar 2. doi: 10.1097/MNM.0000000000000819.
    PubMed     Text format     Abstract available


  100. CALLAN PD, Bhandari S, Clark AL, Eadington D, et al
    The utility of myocardial perfusion imaging before renal transplantation: a retrospective analysis.
    Nucl Med Commun. 2018;39:228-235.
    PubMed     Text format     Abstract available


    February 2018
  101. THIENTUNYAKIT T, Sethanandha C, Muangpaisan W, Chawalparit O, et al
    Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer's disease: first-hand experience in Thailand.
    Nucl Med Commun. 2018;39:186-192.
    PubMed     Text format    


  102. DING X, Man X, Sun M, Xing J, et al
    Which is the optimal threshold for defining functional lung in single-photon emission computed tomography lung perfusion imaging of lung cancer patients?
    Nucl Med Commun. 2018;39:103-109.
    PubMed     Text format     Abstract available


  103. HEDON C, Huet F, Ben Bouallegue F, Vernhet H, et al
    Area at risk can be assessed by iodine-123-meta-iodobenzylguanidine single-photon emission computed tomography after myocardial infarction: a prospective study.
    Nucl Med Commun. 2018;39:118-124.
    PubMed     Text format     Abstract available


    January 2018
  104. BIBBO G, Sigalas V, Kirkwood I
    A review of paediatric administered radiopharmaceutical activities to determine compliance with prescription guidelines.
    Nucl Med Commun. 2018 Jan 30. doi: 10.1097/MNM.0000000000000800.
    PubMed     Text format     Abstract available


  105. HAROON A, Afaq A, Nuthakki S, Freeman A, et al
    Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with 68Ga-PSMA, radiolabelled choline and 68Ga-DOTATATE.
    Nucl Med Commun. 2018 Jan 30. doi: 10.1097/MNM.0000000000000797.
    PubMed     Text format     Abstract available


  106. BRAGHIROLI MI, Mota JM, Duarte PS, Morita TO, et al
    Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer.
    Nucl Med Commun. 2018 Jan 29. doi: 10.1097/MNM.0000000000000810.
    PubMed     Text format     Abstract available


  107. EVANGELISTA L, Cuppari L, Guttilla A, Gardi M, et al
    Oligometastatic recurrent prostate cancer detects by fluorine-18-choline positron emission tomography/computed tomography in patients with prostate-specific antigen levels of up to 5 ng/ml.
    Nucl Med Commun. 2018 Jan 29. doi: 10.1097/MNM.0000000000000808.
    PubMed     Text format     Abstract available


  108. MITTAL BR, Sood A, Shukla J, Vatsa R, et al
    99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes.
    Nucl Med Commun. 2018 Jan 29. doi: 10.1097/MNM.0000000000000802.
    PubMed     Text format     Abstract available


  109. CAYIR D, Araz M, Yalcindag A, Cakal E, et al
    The relationship between semiquantitative parameters derived from technetium-99m metoxyisobutylisonitrile dual-phase parathyroid single-photon emission computed tomography images and disease severity in primary hyperparathyroidism.
    Nucl Med Commun. 2018 Jan 22. doi: 10.1097/MNM.0000000000000803.
    PubMed     Text format     Abstract available


  110. LEI J, Zhao X, Xu B, Duan Z, et al
    Global scientific productivity in the field of PET: a 10-year survey of research activities.
    Nucl Med Commun. 2018 Jan 19. doi: 10.1097/MNM.0000000000000805.
    PubMed     Text format     Abstract available


  111. OSBORNE DR, Acuff SN, Neveu ML, Syed M, et al
    Feasibility assessment of yttrium-90 liver radioembolization imaging using amplitude-based gated PET/CT.
    Nucl Med Commun. 2018 Jan 18. doi: 10.1097/MNM.0000000000000794.
    PubMed     Text format     Abstract available


  112. BROOS WAM, van der Zant FM, Wondergem M, Knol RJJ, et al
    Accuracy of 18F-NaF PET/CT in bone metastasis detection and its effect on patient management in patients with breast carcinoma.
    Nucl Med Commun. 2018 Jan 18. doi: 10.1097/MNM.0000000000000807.
    PubMed     Text format     Abstract available


  113. WOJCIUK G, Kruszewski M
    [DTPA-(PABn)-Leu5]-des-acyl ghrelin(1-5) as a new carrier of radionuclides and potential precursor of radiopharmaceuticals.
    Nucl Med Commun. 2018 Jan 8. doi: 10.1097/MNM.0000000000000790.
    PubMed     Text format     Abstract available


  114. HALL DO, Hooper CE, Searle J, Darby M, et al
    18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma.
    Nucl Med Commun. 2018 Jan 3. doi: 10.1097/MNM.0000000000000789.
    PubMed     Text format     Abstract available


  115. WU X, Gu H, Gao Y, Li B, et al
    Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
    Nucl Med Commun. 2018;39:22-27.
    PubMed     Text format     Abstract available


    December 2017
  116. LENGANA T, van de Wiele C, Lawal I, Maes A, et al
    68Ga-PSMA-HBED-CC PET/CT imaging in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study.
    Nucl Med Commun. 2017 Dec 18. doi: 10.1097/MNM.0000000000000791.
    PubMed     Text format     Abstract available


  117. MHLANGA JC, Chirindel A, Lodge MA, Wahl RL, et al
    Quantitative PET/CT in clinical practice: assessing the agreement of PET tumor indices using different clinical reading platforms.
    Nucl Med Commun. 2017 Dec 8. doi: 10.1097/MNM.0000000000000786.
    PubMed     Text format     Abstract available


  118. DAVIDSON T, Komisar O, Korach J, Felder S, et al
    Physiologic uptake of 18F-FDG in transposed ovaries may mimic metastasis on 18F-FDG PET/CT imaging.
    Nucl Med Commun. 2017 Dec 5. doi: 10.1097/MNM.0000000000000785.
    PubMed     Text format     Abstract available


    November 2017
  119. ZHOU Z, Liu X, Hu K, Zhang F, et al
    The clinical value of PET and PET/CT in the diagnosis and management of suspected cervical cancer recurrence.
    Nucl Med Commun. 2017 Nov 20. doi: 10.1097/MNM.0000000000000775.
    PubMed     Text format     Abstract available


  120. RADHAKRISHNAN RK, Mittal BR, Basher RK, Prakash G, et al
    Post-therapy lesions in patients with non-Hodgkin's lymphoma characterized by 18F-FDG PET/CT-guided biopsy using automated robotic biopsy arm.
    Nucl Med Commun. 2017 Nov 20. doi: 10.1097/MNM.0000000000000780.
    PubMed     Text format     Abstract available


  121. WEBB HR, Latifi HR, Griffeth LK
    Utility of whole-body (head-to-toe) PET/CT in the evaluation of melanoma and sarcoma patients.
    Nucl Med Commun. 2017 Nov 17. doi: 10.1097/MNM.0000000000000778.
    PubMed     Text format     Abstract available


  122. JIANG M, Chen P, Ruan X, Xu W, et al
    Interim 18F-FDG PET/CT and BCL2 for predicting the prognosis of patients with diffuse large B-cell lymphoma in the rituximab era.
    Nucl Med Commun. 2017 Nov 17. doi: 10.1097/MNM.0000000000000784.
    PubMed     Text format     Abstract available


  123. EGE AKTAS G, Tastekin E, Sarikaya A
    Assessment of biological and clinical aggressiveness of invasive ductal breast cancer using baseline 18F-FDG PET/CT-derived volumetric parameters.
    Nucl Med Commun. 2017 Nov 10. doi: 10.1097/MNM.0000000000000779.
    PubMed     Text format     Abstract available


  124. YANO K, Kondo K, Nanashima A, Fujii Y, et al
    Preoperative maximal removal rate of technetium-99m-galactosyl-human serum albumin of the remnant liver is associated with postoperative tumor relapse in hepatitis C virus-related hepatocellular carcinoma.
    Nucl Med Commun. 2017 Nov 2. doi: 10.1097/MNM.0000000000000773.
    PubMed     Text format     Abstract available


  125. RAZAVI S, Ziebarth B, Klein R, Zeng W, et al
    Dual time-point quantitative SPECT-CT parathyroid imaging using a single computed tomography: feasibility and operator variability.
    Nucl Med Commun. 2017 Nov 2. doi: 10.1097/MNM.0000000000000761.
    PubMed     Text format     Abstract available


  126. VALLOT D, Caselles O, Chaltiel L, Fernandez A, et al
    A clinical evaluation of the impact of the Bayesian penalized likelihood reconstruction algorithm on PET FDG metrics.
    Nucl Med Commun. 2017;38:979-984.
    PubMed     Text format     Abstract available


    October 2017
  127. VALLOT D, Caselles O, Chaltiel L, Fernandez A, et al
    A clinical evaluation of the impact of the Bayesian penalized likelihood reconstruction algorithm on PET FDG metrics.
    Nucl Med Commun. 2017 Oct 18. doi: 10.1097/MNM.0000000000000729.
    PubMed     Text format     Abstract available


  128. GOENSE L, Heethuis SE, van Rossum PSN, Voncken FEM, et al
    Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.
    Nucl Med Commun. 2017 Oct 11. doi: 10.1097/MNM.0000000000000771.
    PubMed     Text format     Abstract available


  129. NGUYEN DL, de Labriolle-Vaylet C, Durand E, Fernandez PX, et al
    Reproducibility of differential renal function measurement using technetium-99m-ethylenedicysteine dynamic renal scintigraphy: a French prospective multicentre study.
    Nucl Med Commun. 2017 Oct 3. doi: 10.1097/MNM.0000000000000769.
    PubMed     Text format     Abstract available


  130. BAILLY P, Bouzerar R, Shields T, Meyer ME, et al
    Benefits of respiratory-gated 18F-FDG PET acquisition in lung disease.
    Nucl Med Commun. 2017 Oct 3. doi: 10.1097/MNM.0000000000000772.
    PubMed     Text format     Abstract available


  131. PARK HL, Yoo IR, O JH, Kim H, et al
    Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI.
    Nucl Med Commun. 2017 Oct 3. doi: 10.1097/MNM.0000000000000768.
    PubMed     Text format     Abstract available


  132. WOODS AM, Bolster AA, Han S, Poon FW, et al
    Dual-isotope subtraction SPECT-CT in parathyroid localization.
    Nucl Med Commun. 2017 Oct 3. doi: 10.1097/MNM.0000000000000765.
    PubMed     Text format     Abstract available


  133. KIM K, Kim SJ, Song SH, Kim IJ, et al
    Factors associated with diffusely increased renal uptake of Tc-99m diphosphono-propanedicarboxylic acid on bone scintigraphy in patients with end-stage renal disease.
    Nucl Med Commun. 2017 Oct 3. doi: 10.1097/MNM.0000000000000767.
    PubMed     Text format     Abstract available



  134. Brown adipose tissue detected by PET/CT imaging is associated with less central obesity: Erratum.
    Nucl Med Commun. 2017;38:883.
    PubMed     Text format    


  135. LOU J, Wen G, Dong K, Zhang Y, et al
    Early monitoring of osteoporosis treatment response by technetium-99m-methylene diphosphonate bone scan.
    Nucl Med Commun. 2017;38:854-857.
    PubMed     Text format     Abstract available


    September 2017
  136. TULSYAN S, Das CJ, Tripathi M, Seth A, et al
    Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer.
    Nucl Med Commun. 2017 Sep 27. doi: 10.1097/MNM.0000000000000749.
    PubMed     Text format     Abstract available


  137. WU Q, Luo W, Zhao Y, Xu F, et al
    The utility of 18F-FDG PET/CT for the diagnosis of adrenal metastasis in lung cancer: a PRISMA-compliant meta-analysis.
    Nucl Med Commun. 2017 Sep 25. doi: 10.1097/MNM.0000000000000757.
    PubMed     Text format     Abstract available


  138. USMANI S, Marafi F, Esmail A, Ahmed N, et al
    A proof-of-concept study analyzing the clinical utility of fluorine-18-sodium fluoride PET-CT in skeletal staging of oncology patients with end-stage renal disease on dialysis.
    Nucl Med Commun. 2017 Sep 25. doi: 10.1097/MNM.0000000000000759.
    PubMed     Text format     Abstract available


  139. MEYRICK DP, Asokendaran M, Skelly LA, Lenzo NP, et al
    The role of 68Ga-PSMA-I&T PET/CT in the pretreatment staging of primary prostate cancer.
    Nucl Med Commun. 2017 Sep 15. doi: 10.1097/MNM.0000000000000738.
    PubMed     Text format     Abstract available


  140. PURANDARE NC, Puranik A, Shah S, Agrawal A, et al
    Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation?
    Nucl Med Commun. 2017 Sep 15. doi: 10.1097/MNM.0000000000000753.
    PubMed     Text format     Abstract available


  141. MARTINEZ-AMADOR N, Jimenez-Bonilla J, Martinez-Rodriguez I, De Arcocha-Torres M, et al
    Value of the visual and semiquantitative analysis of carbon-11-methionine PET/CT in brain tumors' recurrence versus post-therapeutic changes.
    Nucl Med Commun. 2017 Sep 12. doi: 10.1097/MNM.0000000000000754.
    PubMed     Text format     Abstract available


  142. KHAZAEE M, Kamali-Asl A, Geramifar P, Rahmim A, et al
    Low-dose 90Y PET/CT imaging optimized for lesion detectability and quantitative accuracy: a phantom study to assess the feasibility of pretherapy imaging to plan the therapeutic dose.
    Nucl Med Commun. 2017 Sep 11. doi: 10.1097/MNM.0000000000000742.
    PubMed     Text format     Abstract available


  143. PANDEY AK, Bisht CS, Sharma PD, ArunRaj ST, et al
    Identification of optimal mask size parameter for noise filtering in 99mTc-methylene diphosphonate bone scintigraphy images.
    Nucl Med Commun. 2017 Sep 6. doi: 10.1097/MNM.0000000000000745.
    PubMed     Text format     Abstract available


  144. THOMAS BA, Molton JS, Leek F, Pang Y, et al
    A comparison of 18F-FDG PET/MR with PET/CT in pulmonary tuberculosis.
    Nucl Med Commun. 2017 Sep 6. doi: 10.1097/MNM.0000000000000743.
    PubMed     Text format     Abstract available


  145. PLOUZNIKOFF N, Arsenault F
    Clinical relevance of 18F-FDG PET/CT lower-limb imaging in patients with malignant cutaneous melanoma.
    Nucl Med Commun. 2017 Sep 6. doi: 10.1097/MNM.0000000000000747.
    PubMed     Text format     Abstract available


    August 2017
  146. SHARIFPOUR R, Ghafarian P, Rahmim A, Ay MR, et al
    Quantification and reduction of respiratory induced artifacts in positron emission tomography/computed tomography using the time-of-flight technique.
    Nucl Med Commun. 2017 Aug 31. doi: 10.1097/MNM.0000000000000732.
    PubMed     Text format     Abstract available


  147. USLU-BESLI L, Kabasakal L, Sager S, Cicik E, et al
    Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation.
    Nucl Med Commun. 2017 Aug 31. doi: 10.1097/MNM.0000000000000737.
    PubMed     Text format     Abstract available


  148. JIANG C, Liu J, Li L, Kosik RO, et al
    Predictive approaches for post-therapy PET/CT in patients with extranodal natural killer/T-cell lymphoma: a retrospective study.
    Nucl Med Commun. 2017 Aug 29. doi: 10.1097/MNM.0000000000000731.
    PubMed     Text format     Abstract available


  149. SHARMA A, Mohan A, Bhalla AS, Vishnubhatla S, et al
    Role of various semiquantitative parameters of 18F-FDG PET/CT studies for interim treatment response evaluation in non-small-cell lung cancer.
    Nucl Med Commun. 2017 Aug 16. doi: 10.1097/MNM.0000000000000723.
    PubMed     Text format     Abstract available


  150. MORRIS M, Saboury B, Chen W, Siegel EL, et al
    Finding the sweet spot for metformin in 18F-FDG-PET.
    Nucl Med Commun. 2017 Aug 10. doi: 10.1097/MNM.0000000000000728.
    PubMed     Text format     Abstract available


  151. SARIKAYA I, Elgazzar AH, Sarikaya A, Alfeeli M, et al
    Normal bone and soft tissue distribution of fluorine-18-sodium fluoride and artifacts on 18F-NaF PET/CT bone scan: a pictorial review.
    Nucl Med Commun. 2017 Aug 3. doi: 10.1097/MNM.0000000000000720.
    PubMed     Text format     Abstract available


  152. HUIZING ED, van Dijk JD, van Dalen JA, Timmer JR, et al
    Minimizing rubidium-82 tracer activity for relative PET myocardial perfusion imaging.
    Nucl Med Commun. 2017;38:708-714.
    PubMed     Text format     Abstract available


  153. AL-MOHAMMAD A, Norton MY, Welch AE, Walton S, et al
    Characterization of viability, scarring and hibernation of the myocardium supplied by epicardial coronary arteries with low flow grades.
    Nucl Med Commun. 2017;38:657-665.
    PubMed     Text format     Abstract available


  154. HUAN W, Aiqin W, Jianping L, Qianqian X, et al
    Radiosynthesis and in-vivo evaluation of [125I]IBT: a single-photon emission computed tomography radiotracer for alpha7-nicotinic acetylcholine receptor imaging.
    Nucl Med Commun. 2017;38:683-693.
    PubMed     Text format     Abstract available


  155. PAREKH A, Graham R, Redman S
    Ventilation/perfusion single-photon emission computed tomography: a service evaluation.
    Nucl Med Commun. 2017;38:672-675.
    PubMed     Text format     Abstract available


    July 2017
  156. LANZA E, Donadon M, Felisaz P, Mimmo A, et al
    Refining the management of patients with hepatocellular carcinoma integrating 11C-choline PET/CT scan into the multidisciplinary team discussion.
    Nucl Med Commun. 2017 Jul 18. doi: 10.1097/MNM.0000000000000719.
    PubMed     Text format     Abstract available


  157. MARAFI F, Esmail A, Rasheed R, Alkandari F, et al
    Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
    Nucl Med Commun. 2017 Jul 18. doi: 10.1097/MNM.0000000000000706.
    PubMed     Text format     Abstract available


  158. GORIN MA, Mareshdeh W, Ross AE, Allaf ME, et al
    Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsi.
    Nucl Med Commun. 2017 Jul 12. doi: 10.1097/MNM.0000000000000716.
    PubMed     Text format     Abstract available


  159. MOREAU A, Giraudet AL, Kryza D, Borson-Chazot F, et al
    Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.
    Nucl Med Commun. 2017 Jul 12. doi: 10.1097/MNM.0000000000000708.
    PubMed     Text format     Abstract available


  160. DEMIRKAYA O, AlQahtani M, Alsugair A, Aras O, et al
    Analysis of metastatic involvement in bone using anatomical and functional information from 18F-FDG PET/CT.
    Nucl Med Commun. 2017 Jul 12. doi: 10.1097/MNM.0000000000000714.
    PubMed     Text format     Abstract available


  161. LEE JW, Lee EY, Hong SY, Yoo ID, et al
    The clinical significance of technetium-99m methylene diphosphonate bone scintigraphy findings in patients with rhabdomyolysis.
    Nucl Med Commun. 2017 Jul 7. doi: 10.1097/MNM.0000000000000709.
    PubMed     Text format     Abstract available


  162. CIFTCI E, Turgut B, Cakmakcilar A, Erturk SA, et al
    Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
    Nucl Med Commun. 2017 Jul 7. doi: 10.1097/MNM.0000000000000712.
    PubMed     Text format     Abstract available


  163. DONG H, Zhang Z, Guo Y, Zhang H, et al
    The application of technetium-99m-red blood cell scintigraphy in the diagnosis of orbital cavernous hemangioma.
    Nucl Med Commun. 2017 Jul 7. doi: 10.1097/MNM.0000000000000711.
    PubMed     Text format     Abstract available


  164. SHEIKHBAHAEI S, Ahn SJ, Young B, Taghipour M, et al
    Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancer.
    Nucl Med Commun. 2017 Jul 3. doi: 10.1097/MNM.0000000000000707.
    PubMed     Text format     Abstract available


  165. MATESAN MM, Bowen SR, Chapman TR, Miyaoka RS, et al
    Assessment of functional liver reserve: old and new in 99mTc-sulfur colloid scintigraphy.
    Nucl Med Commun. 2017;38:577-586.
    PubMed     Text format     Abstract available


  166. HANNEY MB, Hillel PG, Scott AD, Lorenz E, et al
    Half-body single photon emission computed tomography with resolution recovery for the evaluation of metastatic bone disease: implementation into routine clinical service.
    Nucl Med Commun. 2017;38:623-628.
    PubMed     Text format     Abstract available


  167. TAYLOR JC, Murray AW, Hall DO, Barnfield MC, et al
    UK audit of quantitative thyroid uptake imaging.
    Nucl Med Commun. 2017;38:608-616.
    PubMed     Text format     Abstract available


    June 2017
  168. MALLORIE A, Goldring J, Patel A, Lim E, et al
    Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumour SUVmax/2 has the highest specificity.
    Nucl Med Commun. 2017 Jun 27. doi: 10.1097/MNM.0000000000000703.
    PubMed     Text format     Abstract available


  169. YANO K, Nanashima A, Fujii Y, Hiyoshi M, et al
    Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin is correlated with liver functional parameters, but did not predict postoperative morbidity.
    Nucl Med Commun. 2017 Jun 22. doi: 10.1097/MNM.0000000000000702.
    PubMed     Text format     Abstract available


  170. GUO R, Wang J, Zhang M, Zhang M, et al
    Value of 99mTc-MIBI SPECT/CT parathyroid imaging and ultrasonography for concomitant thyroid carcinoma.
    Nucl Med Commun. 2017 Jun 13. doi: 10.1097/MNM.0000000000000692.
    PubMed     Text format     Abstract available


  171. LAFFON E, Milpied N, Marthan R
    Measurement uncertainty of lesion and reference mediastinum standardized uptake value in lung cancer.
    Nucl Med Commun. 2017;38:509-514.
    PubMed     Text format     Abstract available


  172. NORIEGA-ALVAREZ E, Martinez Pimienta GA, Benitez Segura AM, Bajen Lazaro MT, et al
    Utility of 8 h and time decay-corrected acquisition scintigraphy with in-vitro labeled white blood cells for the diagnosis of osteoarticular infection.
    Nucl Med Commun. 2017;38:500-508.
    PubMed     Text format     Abstract available


  173. HUA Q, Zhu X, Zhang L, Zhao Y, et al
    Initial experience with real-time hybrid single-photon emission computed tomography/computed tomography-guided percutaneous transthoracic needle biopsy.
    Nucl Med Commun. 2017;38:556-560.
    PubMed     Text format     Abstract available


  174. LEE GH, Lee JH
    Clinical significance of incidental prostatic fluorine-18-fluorodeoxyglucose uptake in the diagnosis of infectious prostatitis in adult males.
    Nucl Med Commun. 2017;38:523-528.
    PubMed     Text format     Abstract available


    May 2017
  175. DUBREUIL J, Salles G, Bozzetto J, Tordo J, et al
    Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review.
    Nucl Med Commun. 2017 May 31. doi: 10.1097/MNM.0000000000000697.
    PubMed     Text format     Abstract available


  176. GOLUBIC AT, Pasini Nemir E, Zuvic M, Mutvar A, et al
    The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values.
    Nucl Med Commun. 2017 May 30. doi: 10.1097/MNM.0000000000000696.
    PubMed     Text format     Abstract available


  177. HAS SIMSEK D, Sanli Y, Kulle CB, Karanlik H, et al
    Correlation of 18F-FDG PET/CT with pathological features and survival in primary breast cancer.
    Nucl Med Commun. 2017 May 26. doi: 10.1097/MNM.0000000000000694.
    PubMed     Text format     Abstract available


  178. GREEN AL, Bagci U, Hussein S, Kelly PV, et al
    Brown adipose tissue detected by PET/CT imaging is associated with less central obesity.
    Nucl Med Commun. 2017 May 15. doi: 10.1097/MNM.0000000000000691.
    PubMed     Text format     Abstract available


  179. SHINJYO M, Naniwa M, Kubo N, Nishimura Y, et al
    Optimal injected dose ratio of a very rapid 1-day protocol of myocardial perfusion imaging with cadmium-zinc-telluride single-photon emission tomography: simulation and phantom study.
    Nucl Med Commun. 2017 May 9. doi: 10.1097/MNM.0000000000000689.
    PubMed     Text format     Abstract available


  180. MA JT, Han CB, Zheng JH, Sun HZ, et al
    Hybrid PET/MRI-based delineation of gross tumor volume in head and neck cancer and tumor parameter analysis.
    Nucl Med Commun. 2017 May 9. doi: 10.1097/MNM.0000000000000687.
    PubMed     Text format     Abstract available


  181. SCHUITEVOERDER D, Grinlington L, Stevens J, Nance R, et al
    Nonvisualized sentinel lymph nodes on lymphoscintigraphy in melanoma: predictive factors and surgical outcomes.
    Nucl Med Commun. 2017;38:383-387.
    PubMed     Text format     Abstract available


  182. HAN J, Liu H, Liu C, Jin H, et al
    Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.
    Nucl Med Commun. 2017;38:372-382.
    PubMed     Text format     Abstract available


  183. HIPPELAINEN ET, Tenhunen MJ, Maenpaa HO, Heikkonen JJ, et al
    Dosimetry software Hermes Internal Radiation Dosimetry: from quantitative image reconstruction to voxel-level absorbed dose distribution.
    Nucl Med Commun. 2017;38:357-365.
    PubMed     Text format     Abstract available


    April 2017
  184. IBALL GR, Bebbington NA, Burniston M, Edyvean S, et al
    A national survey of computed tomography doses in hybrid PET-CT and SPECT-CT examinations in the UK.
    Nucl Med Commun. 2017 Apr 27. doi: 10.1097/MNM.0000000000000672.
    PubMed     Text format     Abstract available


  185. ARMSTRONG IS, Thomson KE, Rowley LM, McGowan DR, et al
    Harmonizing standardized uptake value recovery between two PET/CT systems from different manufacturers when using resolution modelling and time-of-flight.
    Nucl Med Commun. 2017 Apr 25. doi: 10.1097/MNM.0000000000000682.
    PubMed     Text format     Abstract available


  186. GIZEWSKA A, Witkowska-Patena E, Osiecki S, Mazurek A, et al
    Utility of single-photon emission tomography/computed tomography for sentinel lymph node localization in breast cancer patients.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000676.
    PubMed     Text format     Abstract available


  187. YANG CC, Yang BH, Tu CY, Wu TH, et al
    Low-dose computed tomography scans with automatic exposure control for patients of different ages undergoing cardiac PET/CT and SPECT/CT.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000679.
    PubMed     Text format     Abstract available


  188. PRIAMO J, Adamopoulos D, Rager O, Frei A, et al
    Downstream indication to revascularization following hybrid cardiac PET/MRI: preliminary results.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000680.
    PubMed     Text format     Abstract available


  189. MARUOKA Y, Nagao M, Baba S, Isoda T, et al
    Three-dimensional fractal analysis of 99mTc-MAA SPECT images in chronic thromboembolic pulmonary hypertension for evaluation of response to balloon pulmonary angioplasty: association with pulmonary arterial pressure.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000673.
    PubMed     Text format     Abstract available


  190. EVANGELISTA L, Cervino AR, Michieletto S, Saibene T, et al
    Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients.
    Nucl Med Commun. 2017 Apr 13. doi: 10.1097/MNM.0000000000000671.
    PubMed     Text format     Abstract available


  191. UYAMA N, Otsuka H, Shinya T, Otomi Y, et al
    The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Nucl Med Commun. 2017 Apr 13. doi: 10.1097/MNM.0000000000000674.
    PubMed     Text format     Abstract available


  192. VENNART NJ, Bird N, Buscombe J, Cheow HK, et al
    Optimization of PET/CT image quality using the GE 'Sharp IR' point-spread function reconstruction algorithm.
    Nucl Med Commun. 2017 Apr 7. doi: 10.1097/MNM.0000000000000669.
    PubMed     Text format     Abstract available


  193. CHISM CB, Ravizzini GC, Macapinlac HA, Pan T, et al
    Quantitative comparison between regularized time-of-flight and OSEM PET reconstructions for small 18F-FDG-avid lesions.
    Nucl Med Commun. 2017 Apr 5. doi: 10.1097/MNM.0000000000000670.
    PubMed     Text format     Abstract available


  194. HAROON A, Syed R, Endozo R, Allie R, et al
    Spectrum of metastatic and nonmetastatic skeletal findings with dual-phase 18F-FECH PET/CT in patients with biochemical relapse of prostate cancer.
    Nucl Med Commun. 2017 Apr 4. doi: 10.1097/MNM.0000000000000665.
    PubMed     Text format     Abstract available


  195. TAYWADE SK, Ramaiah VL, Basavaraja H, Venkatasubramaniam PR, et al
    Prevalence of ECG changes during adenosine stress and its association with perfusion defect on myocardial perfusion scintigraphy.
    Nucl Med Commun. 2017;38:291-298.
    PubMed     Text format     Abstract available


  196. RAO H, Gaur N, Tipre D
    Assessment of diabetic neuropathy with emission tomography and magnetic resonance spectroscopy.
    Nucl Med Commun. 2017;38:275-284.
    PubMed     Text format     Abstract available


    September 2016

  197. News and Views-September 2016.
    Nucl Med Commun. 2016;37:999.
    PubMed     Text format    


  198. JIANG Z, Liu Y, Xin C, Zhou Y, et al
    Normal stress-only myocardial single photon emission computed tomography predicts good outcome in patients with coronary artery stenoses between 40 and 70.
    Nucl Med Commun. 2016;37:899-903.
    PubMed     Text format     Abstract available


  199. DAVIDSON T, Komissar O, Goshen E, Shalmon B, et al
    Focal fluorine-18 fluorodeoxyglucose-avid parotid findings in patients with lung cancer: prevalence and characteristics.
    Nucl Med Commun. 2016;37:969-74.
    PubMed     Text format     Abstract available


  200. BAHK YW, Chung YA, Lee UY, Park SI, et al
    Gamma correction 99mTc-hydroxymethylene diphosphonate pinhole bone scan diagnosis and histopathological verification of trabecular contusion in young rats.
    Nucl Med Commun. 2016;37:988-91.
    PubMed     Text format     Abstract available


  201. KANGASMAA TS, Constable C, Hippelainen E, Sohlberg AO, et al
    Multicenter evaluation of single-photon emission computed tomography quantification with third-party reconstruction software.
    Nucl Med Commun. 2016;37:983-7.
    PubMed     Text format     Abstract available


  202. SURIYANTO, Ng EY, Say XJ, Ng CE, et al
    Quantitative means for differentiating renal obstruction by analysing renography by compartmental modelling of renal fluid flow rate.
    Nucl Med Commun. 2016;37:904-10.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: